Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26FM46B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,947
Award facts
- Contract value 100% obligated
- $13,946.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $13,946.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Benlysta 200 mg/mL auto-injector. This contract, with an ultimate completion date of February 17, 2026, represents a single task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's capability to compete in open federal procurement. The place of performance is Conshohocken, Pennsylvania, which serves as the corporate office headquarters for AmerisourceBergen Drug Corp.
Benlysta (belimumab) is a biologic immunosuppressant medication used to treat systemic lupus erythematosus and other autoimmune conditions, making this delivery order part of the DLA's broader pharmaceutical supply chain supporting military healthcare systems worldwide. The contract demonstrates AmerisourceBergen's role as a critical supplier of specialty medications and medical supplies to the Defense Health Agency and other federal healthcare programs. The parent company, Cencora, Inc., operates as the primary pharmaceutical distributor for military treatment facilities and veteran healthcare programs through its comprehensive IDC with the DLA.
Quick answers
Who was awarded contract SPE2DR26FM46B?
SPE2DR26FM46B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FM46B worth?
The government has obligated $13,947 on SPE2DR26FM46B.
Is contract SPE2DR26FM46B an order under another contract?
Yes. SPE2DR26FM46B is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM46B competed?
The extent of competition for SPE2DR26FM46B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award